Bulls Eye Closers and After-Hours Surge: Catheter Precision and LIXTE Lead Healthcare Breakout
DENVER, Colo., Aug 18, 2025 (247marketnews.com)- Healthcare names are lighting up the tape heading into the close and after-hours session as regulatory wins, scientific breakthroughs, and fresh financing fuel the moves.
Catheter Precision (NYSE:VTAK) is looking to bounce back in a big way after securing regulatory approval for its LockeT device in the United Kingdom, just three months after earning CE Mark status. The suture retention device, designed for cardiac electrophysiology procedures, supports faster patient discharge and aligns with the NHS’s ongoing push to cut wait times.
The company is leveraging a deepened partnership with UK-based distributor HC21, which boasts €180 million in annual revenue and extensive NHS reach.
“LockeT’s intuitive design and ease of deployment… enable earlier discharge,” noted Fatih Ayoglu, Sales Manager for EMEA & APAC—a comment that’s resonating with investors betting on a rebound from VTAK’s recent 52-week low.
LIXTE Biotechnology (NASDAQ:LIXT) is turning heads after releasing a comprehensive corporate update. LIXTE’s catalyst is Scientific backing for its lead compound LB-100 in a Nature-published study led by Dr. Amir Jazaeri (MD Anderson).
With Roche’s (OTCQX:RHHBY) atezolizumab and GSK’s (NYSE:GSK) dostarlimab both involved in ongoing trials with LB-100 in colorectal and ovarian cancer respectively, LIXTE’s potential to enhance immunotherapy efficacy is attracting serious attention.
Other Movers in Biotech & Pharma
- Propanc Biopharma (NASDAQ:PPCB) uplisted to Nasdaq via a $4.00/share offering, increasing liquidity and institutional visibility.
- Soligenix (NASDAQ:SNGX) earned FDA orphan drug designation for dusquetide in Behçet’s Disease, after Phase 2a data supported its efficacy.
- GoodRx (NASDAQ:GDRX) also saw active trade, riding sentiment in the digital health sector.
⚡ Quick Hits in Tech
- Zepp Health (NYSE:ZEPP) and Applied Optoelectronics (NASDAQ:AAOI) saw volume spikes amid consumer health and optics chatter.
- Cipher Mining (NASDAQ:CIFR) and Applied Digital (NASDAQ:APLD) showed strength as digital infrastructure plays.
For additional 247marketnews.com and LIXT disclosure https://247marketnews.com/lixte-biotechnology/
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (VTAK, LIXT, GSK, BTAI, CIFR, ZEPP)
- Today’s Top Performers: MoBot’s Market Review 08/18/25 12:00 PM
- Healthcare Innovators: Catheter Precision Expands in UK, LIXTE Gains Momentum, BioXcel Nears At-Home Approval Milestone
- LIXTE Biotechnology Issues Corporate Update Amid Strategic Advancements and Scientific Validation
- Catheter Precision Strengthens European Market Foothold with UK Approval for LockeT